Commerce and Industry Minister Piyush Goyal on Sunday called for making the pharmaceutical sector more attractive for investments in clinical trials and research and development, while urging domestic regulators to look at global practices and adopt best practices. He also suggested that the industry develop resilient supply chains and not depend on one or two geographies for necessary imports.
“I don’t mind if there is an import content, which is necessary (for product development). But you have to see if it is available in many geographies or many companies, all over the world, so that no one or two countries or companies can hold a gun and hold you to ransom,” he said here while addressing an event of the pharma sector. He said that depending on one country or company will hurt businesses.